Federal award
REJUVENATE BIO INC.
H9240519C0004
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $1,975,972.00
- Ceiling (potential value, not spending)
- $1,975,972.00
- Current value
- $1,975,972.00
- Gross positive obligations
- $1,975,972.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- REJUVENATE BIO INC. · GEKFSVSTKK55
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- REJUVENATE BIO INC. · GEKFSVSTKK55
- Awarding agency
- Department of War · sub-agency 9763 · office S0514A
- Funding agency
- Department of War · sub-agency 97ZS
- Product or service (PSC)
- AZ13 · R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT)
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- H9240519C0004
- Award type code
- D
- Actions
- 11 · Nov 29, 2018 to Mar 13, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 13, 2023 | FY2023 | ARZ998 | W | $0.00 | — |
| Jun 14, 2022 | FY2022 | P00010 | M | $0.00 | — |
| Aug 16, 2021 | FY2021 | P00009 | M | $0.00 | — |
| Jun 23, 2021 | FY2021 | P00008 | B | $0.00 | — |
| Apr 17, 2020 | FY2020 | P00007 | B | $0.00 | — |
| Feb 25, 2020 | FY2020 | P00006 | B | $534,705.00 | — |
| Oct 29, 2019 | FY2020 | P00005 | C | $441,267.00 | — |
| Apr 3, 2019 | FY2019 | P00004 | M | $0.00 | — |
| Feb 5, 2019 | FY2019 | P00003 | M | $0.00 | — |
| Dec 7, 2018 | FY2019 | P00002 | M | $0.00 | — |
| Nov 29, 2018 | FY2019 | 0 | — | $1,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
